Form Bio Co. Ltd. (377220) — Strategic Asset Allocation Index
Form Bio Co. Ltd. (377220) has a Strategic Asset Allocation Index of 74.7% as of September 2024. Strategic assets (PP&E of ₩46.28 Billion plus long-term investments of ₩-) total ₩46.28 Billion, measured against net assets of ₩61.95 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Form Bio Co. Ltd. balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Form Bio Co. Ltd. Strategic Asset Allocation Index (2020–2022)
This chart shows how Form Bio Co. Ltd.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2024, the index stands at 74.7%, representing strategic assets of ₩46.28 Billion against net assets of ₩61.95 Billion KRW. For live market cap and overall valuation, see 377220 stock market capitalisation.
Annual Strategic Asset Allocation Index for Form Bio Co. Ltd. (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Form Bio Co. Ltd. from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Form Bio Co. Ltd. net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 37.9% | ₩33.31 Billion | ₩33.31 Billion | ₩- | ₩87.96 Billion | ▲ +13.8 pp |
| 2021 | 24.1% | ₩20.33 Billion | ₩20.33 Billion | ₩- | ₩84.43 Billion | ▼ -28.9 pp |
| 2020 | 52.9% | ₩12.51 Billion | ₩12.51 Billion | ₩- | ₩23.64 Billion | — |